Introduction
Toluene is one of the most popular chemicals used in industry as thinner for painting, degreaser of electric parts, material for various chemicals, and for other uses. Toluene is used as a single solvent or a component of solvent mixtures. Acute health effects after inhalation of toluene are symptoms such as fatigue, headache, drowsiness, vertigo, ataxia, etc. 1, 2) . In the case of inhalation exposure to high concentrations of toluene, an anesthetic effect is often observed 3, 4) . In the most serious cases, breathing is terminated due to deep anesthesia. In addition to such acute effects, various brain functions are disordered after long-term inhalation exposure to toluene. Many cases of addiction, anorexia, and memory disorders are reported [5] [6] [7] . Some cases of dementia may be related to exposure to toluene [8] [9] [10] . Thus, the most serious health effects of toluene are considered to be functional disorders of the central nervous system. Beside the direct effects on the nervous system, indirect effects of toluene must be considered in workplaces. If the consciousness level is lowered during work due to exposure to toluene, attention is disrupted and exact judgment may be disturbed. Such a situation often leads to accidents in workplaces. To prevent accidents and intoxications, it is indispensable to know the dose-effect relationship and action mechanism of toluene in the living organism. Many animal studies have been performed regarding toxicity mechanism of toluene. Effects of toluene on the central nervous system have been studied for a long time 11) , but the whole action mechanism of toluene is not as clear as expected. The behavior and action of toluene in the brain needs to be clarified even now.
There are different ways to study the effects of chemicals on the central nervous system. Among them, three approaches, i.e. behavioral, electrophysiological, and biochemical procedures, have often been used. Brain function is maintained by impulse flow inside nerve cells, and impulse flow from nerve cells to the adjacent cells is mediated by neurotransmitters at synapses. Therefore, changes in the events at synapses are in many cases critical to brain function. In the field of neurotoxicity of drugs and chemicals, mechanistic studies have focused on synaptic neurotransmission. The changes in neurotransmission are main targets of the biochemical approach to clarifying the neurotoxic mechanism of chemicals [12] [13] [14] . Acetylcholine (ACh) is one of the most important neurotransmitters in the brain. In our previous study, a shortterm exposure of rats to a high concentration of toluene gas affected brain ACh concentrations and altered ACh metabolism in the brain 15, 16) , and the suppression of ACh release from the cholinergic nerve terminals in rat brain induced by toluene was elucidated by means of microdialysis 17) . Brain microdialysis is a powerful technique to elucidate the neuronal activity in free moving animals, and has developed remarkably during the past two decades [18] [19] [20] , but to the best of our knowledge, details of the effects of toluene exposure on the brain have not been reported yet.
In the present study, we attempted to find the biochemical phenomena which occur in the brain during or after exposure to toluene, and to clarify the mechanism of toxicity, particularly the anesthetic effect produced by exposure to toluene. Other aims of this study were to clarify the dose effects relationships and to detect the threshold exposure conditions to elicit cerebral effects of toluene. For these purposes, changes in cholinergic neurons at synaptic sites after the administration of toluene have been investigated with microdialysis. In our preliminary study, we attempted to apply brain microdialysis to clarify the effects of whole body exposure to toluene on the brain neurotransmitter release in rats, but it was very difficult to make the flow of perfusate constant in our exposure apparatus. Our chambers for inhalation exposure were very large and we had to use long tubes for brain perfusion. It was actually impossible to perfuse through a long fine tube with a very small inner diameter. Therefore, we performed the microdialysis study by injecting toluene without using exposure chambers, and extrapolated the effects of intraperitoneal (i.p.) injection to those of inhalation exposure by using the data on the body content of toluene. The presence of a circadian rhythm in brain neurotransmitter content is known, therefore, the circadian rhythm of ACh in microdialysis was investigated in the first series of the present study.
Materials and Methods

Animals
We used male Sprague-Dawley rats, 14-to 16-week old (Japan Charles River) supplied chow diet (CE-2, Nihon Clea, Tokyo) and tap water ad libitum. All subjects were housed in groups in cages made of stainless-steel wire netting until the experiment. All areas for bleeding and experiments were maintained at 23°C and 55 ± 5% humidity with a barrier system, with lights on from 8:00 a.m. to 8:00 p.m.
Brain microdialysis
Rats were anesthetized with pentobarbital administered intraperitoneally at 60 mg/kg before operation, and placed on a stereotaxic instrument (Narishige Co., Tokyo). Guide cannulae, dialysis probes, and a microinfusion pump (Carnegie Medicine) were purchased from B.A.S. Japan (Tokyo). A guide cannulae was fixed with dental cement to the skull bone, and implanted in the right hemisphere to insert the probe into the striatum or the hippocampus. De Groot's brain atlas 21) was used to determine the brain coordinates. The rats were allowed to recover from the surgery for 3 to 5 d. After the implantation of guide cannulae on the skull bone, the rats were housed individually in plastic cages specially made for cannulae-implanted animals after surgery. Coordinates for the striatum were as follows; anterior 7.8 mm, lateral 3.3 mm, and depth from the brain surface 5.5 mm. Coordinates for the hippocampus were as follows; anterior 2.2 mm, lateral 5.0 mm, and depth from the brain surface 5.0 mm. After recovery, a dialysis probe was inserted into the brain through the guide cannulae, and perfused at the rate of 1 µl/min with an artificial cerebrospinal fluid (140 mM NaCl, 3 mM KCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , 1.2 mM Na 2 HPO 4 , 0.3 mM NaH 2 PO 4 , 3 mM glucose, pH 7.2). The perfusion was started at 10:00 a.m. The perfusate was collected every 30 min (providing 30 µl perfusate). When the experiment was completed, the rats were decapitated and brain slices were made to determine the sites of the implanted probes.
Administration and inhalation exposure of chemicals
Rats received i.p. injection of toluene (Wako Pure Chemicals, Kyoto) dissolved in olive oil (Wako). Control rats were given olive oil only. The volume of olive oil injected was adjusted to 2 ml/kg body weight both in control and dosed rats.
Toluene gas for the inhalation exposure obtained by the saturation method was prepared at such desired concentrations as 1,000 ppm by mixing with clean air, then introduced into the inhalation chambers 22, 23) . The mixing of toluene gas with air was performed in dilution chambers (Sibata, Tokyo). The concentrations of toluene in the chambers were monitored every 20 min by a gas chromatograph equipped with a flame ionization detector (Shimadzu, Kyoto). Actual concentrations in the exposure chambers were between the target value ± 5% in each concentration.
Extraction of brain substances
After i.p. administration of toluene solution, the rats were sacrificed by microwave power, 1.5 KW 0.8 s, focused on the head (Microwave applicator, Muromachi Kikai Co., Tokyo). Rat brains were dissected into small brain areas, i.e. frontal cortex, occipital cortex, hippocampus, striatum, midbrain, hypothalamus, medulla oblongata, and cerebellum according to the method of Glowinski and Iversen 24) , and stored at -80°C prior to homogenization. Small brain areas were homogenized with Potter-Elvehjam homogenizer in 0.2 N HClO 4 containing 1 mM EDTA and 5 mM Na 2 S 2 O 5 . The homogenate was centrifuged at 1,000 g for 20 min at 4°C, and the supernatant was used for high performance liquid chromatography (HPLC) analysis. The supernatants were filtered in a centrifugation filter tube with a 0.45 µm pore size filter before the application to HPLC.
Analysis of perfusates and brain extracts by HPLC
The perfusates of microdialysis and extracts from the brain homogenates were assayed for ACh by HPLC equipped with an electrochemical detector (ECD-100, Eicom Co., Kyoto, Japan). ACh, choline, and ethylhomocholine (internal standard), were separated on a reverse phase ion pair chromatography column (Eicompak AC-GEL, Eicom) with a mobile phase comprising 0.1 M phosphate buffer, pH 8.2. One liter of this buffer contained 200 mg of sodium 1-decanesulphonate, 65 mg of tetramethylammonium chloride, and 3.72 mg of EDTA · Na 2 · H 2 O 25) . Eluates were introduced into a column that fixed two enzyme, ACh esterase and choline oxidase (AC Enzymepak, Eicom). Column temperature was maintained at 30°C in a column oven. An HPLC pump (L-4000, Hitachi Co., Tokyo) was used at a flow rate of 0.6 ml/ min. ACh, choline, and ethylhomocholine were assayed with an electrochemical detector by measuring the amount of H 2 O 2 produced by the enzyme reaction from these three compounds. The voltage used for electrochemical detection was 450 mV.
Extraction and analysis of toluene in rat tissues
In i.p. administration, rats were given 50, 200 or 1,000 mg/kg of toluene dissolved in olive oil. They were sacrificed 2, 4, 8, 24 or 48 h after the injection and the blood and organs were taken out. In the inhalation experiment, rats were exposed to toluene vapor at 50, 200 or 1,000 ppm for 8 h. They were sacrificed 0.5, 3, 6 or 24 h after the termination of inhalation to take out the blood and organs.
We determined the concentrations of toluene in blood, brain, liver and adipose tissue with a GC-MS (a Hewlett-Packard gas chromatograph 6890 equipped with a Hewlett-Packard mass-selective detector 5973). A capillary column HPINNOWax was attached to the gas chromatograph. Analytical conditions: injected sample volume was 1 µl; the splitless mode was selected; inlet temperature was 150 °C; the constant flow-rate of helium carrier gas was 1.5 ml/min; the size of the capillary column was 30.0 m × 250 µm × 0.25 µm; the constant oven temperature was 50°C; ionization was carried out in the electron impact (EI) mode; the single ion method mode was selected and detected ions were 91, 92, 107 and 109 m/z.
Toluene was extracted from blood and tissues with nhexane (n-hexane 1000, Wako) including 1, 2-dibromoethane as an internal standard. The stability of 1, 2-dibromoethane was confirmed during the analysis. Two milliliters of blood was pipetted into a glass test tube, 2 ml of n-hexane including internal standard was added, and the mixture was thoroughly shaken. The upper layer was transferred to another bottle after centrifugation, and then was used for analysis. One gram of tissue was put into a glass test tube, and 2 ml of nhexane including the internal standard was added. The tissue was homogenized with a Polytron (Kinematica GHBH. Lucerne, Switzerland), and centrifuged. The upper layer was used for analysis. The linearity of the standard curve was appraised from 0 (internal standard only) to 939.0 nmol/ ml (86.52 µg/ml) at 10 points.
Statistics
Dunnett's multiple t-test in a statistical program (SPSS Japan Inc.) compared controls and each of the exposed groups. Differences between groups at p<0.05 were considered significant.
Results
Circadian rhythms
To investigate the circadian rhythms of brain ACh, timecourse changes in the extracellular concentration of ACh in the brain striatum were measured in freely moving rats by microdialysis under no treatment with chemicals. At 10:00 a.m. on the first day of measurement, a dialysis probe was inserted into the guide canullae and perfusion was started. Figure 1 shows the time course of the brain ACh levels obtained from 3 rats. ACh levels were stable between 02:00 and 06:00 p.m., therefore, the mean of ACh level, 892 nmol/ l perfusate, between these times was set at 100% as the control. As shown in Fig. 1 , ACh levels measured by microdialysis were between 80 and 120% of the control value and almost constant throughout the 31 h between 10:00 a.m. on the first day and 05:00 p.m. on the next day. This result means the absence of circadian rhythms in the extracelluar concentration of ACh in the brain striatum.
Effects of toluene injection on the extracellular levels of ACh in the brain
To measure the effects of toluene on the extracellular concentration of the brain ACh, toluene was injected into the rats during the microdialysis. The dialysis probe was inserted into the brain striatum and perfusion was started at 10:00 a.m. Measurement of ACh concentrations in the perfusate was performed for 10 h between 10:00 a.m. and 08:00 p.m. The i.p. injection of toluene was done at 02:00 p.m. Toluene was dosed at 200, 500, 1,000 and 2,000 mg/ kg to each group of rats. Three to four rats were used for each group including the control. Figures 2a and 2b show the concentrations of ACh in the perfusate before and after the injection. In each rat, the mean value obtained from four determinations between 12:00 a.m. and 02:00 p.m. was set at 100% as a pre-injection control value, and each determination was expressed as a percentage of this control value. In control rats dosed only with olive oil vehicle, the ACh concentration in the perfusate was not altered by the injection of the vehicle for toluene as shown in Fig. 2a (upper) . In rats which received toluene at 200 mg/kg, ACh levels in the perfusate were slightly lower than the control at 1.5 h after the injection (Fig. 2a, middle) , but statistical significance was not obtained by Dunnett's test. In the 500 mg/kg group, ACh levels were lowered by the injection and statistical significance was obtained at 1.5 to 3 h after the injection (Fig. 2a, lower) . In rats given toluene at 1,000 mg/kg, a significant decrease in ACh levels was observed between 1.5 and 4 h after the injection. The lowest ACh level was about 50% of the control, and ACh levels returned to the control level at 5.5 h after the injection (Fig. 2b, upper) . After the injection of toluene at 2,000 mg/kg, the ACh level was reduced by about 80% and returned to the control level at 5.5-6 h after the injection (Fig. 2b, lower) . Figure 3 shows ACh levels in each group at their lowest time point. ACh levels were decreased by the toluene injection in a dosedependent manner, and significant differences from the control were observed at 500 mg/kg or higher doses.
In the next series of experiment, a dialysis probe was inserted into the brain hippocampus and toluene was injected at doses of 200 and 1,000 mg/kg. Figure 4 shows the effects of toluene on ACh levels in the hippocampus. As in the case of microdialysis in the striatum, the mean value obtained from four determinations, 215 nmol/l perfusate, between 12:00 a.m. and 02:00 p.m. was set at 100% as a pre-injection control value in each rat. In control rats, the extracellular ACh concentration was not altered by the vehicle injection (Fig. 4, upper) . In rats which received toluene at 200 mg/ kg, ACh levels were lowered slightly at 2-3 h after the injection (Fig. 4, middle) , but the lowered levels were not statistically different from the pre-injection control. In the 1,000 mg/kg group, decreases in ACh levels were apparent and statistical significance was obtained at 3 to 4 h after the injection (Fig. 4, lower) . The lowest ACh level was about 50% of the control, and returned to the control level at 5.5 h after the injection.
Effects of i.p. injection of pentobarbital on the extracellular ACh levels in the brain
Rats received i.p. administration of pentobarbital, 60 mg/ kg, in a microdialysis study, and the effects of pentobarbital on the release of ACh from nerve terminals in the striatum were evaluated. The experiment procedures were the same as those in toluene administration. Measurement of ACh in the perfusate was started at 10:00 a.m. and was continued for 10 h. Pentobarbital was injected intraperitoneally at 02:00 p.m. The mean value obtained from four determinations between 12:00 a.m. and 02:00 p.m. was set at 100% as a pre-injection control value in each rat. Four and three rats were used for control and pentobarbital groups, respectively. Figure 5 (upper and lower) shows the time-course changes in perfusate concentrations of ACh in the control and pentobarbital groups, respectively. In olive-treated control rats, the ACh concentration in the perfusate showed no change from 100%. In rats which received pentobarbital, ACh levels were lowered just after the injection and reached the minimum at 2-2.5 h after the injection, where ACh levels were lower than detectable limit. At 4.5 h after the injection, ACh levels had recovered and reached the pre-injection level.
Effects of i.p. injection of toluene on ACh content of brain homogenate
To measure the effects of toluene on the brain ACh, rats received i.p. administration of toluene once a day for 7 d and were sacrificed 2 h after the last injection. ACh concentrations in the striatum and hippocampus were measured by analyzing ACh content of the homogenate. Doses of toluene were 200, 500 and 1,000 mg/kg. Toluene was administered between 01:00 p.m. and 03:00 p.m. Five rats were used for each group including the control. Figures  6 and 7 show the results of ACh measurement in the stratum and hippocampus, respectively. As Fig. 6 shows, the ACh concentration in the homogenate of the striatum was increased by toluene in a dose dependent fashion at 200 mg/kg or higher, but statistical significance was not obtained at 200 and 500 mg/kg in Dunnett's test. In 1,000 mg/kg groups, ACh concentrations were significantly higher than the control. The increase in ACh at 1,000 mg/kg was 56% of the control. Mean ACh content of the striatum in the control group was 39.7 ng/g tissue. As shown in Fig. 7 , the ACh concentration in the homogenate of the hippocampus was increased by toluene dose-dependently. Statistical significance was obtained at 1,000 mg/kg, and ACh had increased by 46% at 1,000 mg/kg compared to the control value. Mean ACh content of the hippocampus in the control group was 17.3 ng/g tissue.
Tissue concentration of toluene
The time course of the toluene concentration in rat tissues after the injection of, or inhalation exposure to, toluene is shown in Fig. 8 . Tissue toluene decreased exponentially after the injection and the termination of inhalation, and the time courses in both cases are parallel. With these data, we calculated a simplified simulation model of the time course of tissue toluene (Fig. 9) and calculated the time integration of the amount of toluene in blood, brain, liver and adipose tissue (Table 1 ). In this model, the tissue toluene concentration increased quickly and linearly after the i.p. injection or the initiation of inhalation, and reached maximal levels. In inhalation cases, constant levels of tissue toluene continued for almost 8 h. Figure 10 shows the correlation of the injection dose or exposure concentration of toluene with tissue toluene levels in blood and brain. In inhalation exposure cases, tissue toluene levels were linearly dependent on the exposure concentrations, but tissue toluene levels in injection cases tended to be saturated in higher doses.
Discussion
The circadian rhythms are known to be present in the brain concentration of neurotransmitters such as serotonin 26) . As revealed by the present experiment, circadian rhythms at the extracellular concentration of ACh in the brain striatum were absent.
The i.p. injection of toluene reduced extracellular ACh in a dose dependent manner. Injection of high doses of toluene, 1,000 to 2,000 mg/kg, noticeably reduced the concentration of extracellular ACh in the striatum and hippocampus. These results mean that the i.p. injection of toluene reduces the ACh release from the cholinergic nerve terminals in the striatum and hippocampus. A significant decease in ACh release in the striatum was observed at 500 mg/kg or higher doses, but ACh tended to decrease even at 200 mg/kg both in the striatum and hippocampus. These results suggest that the decrease in ACh release might occur in many brain areas due to the injection of toluene. At 200 mg/kg, slight ataxia and gait disturbance were observed. At 1,000 mg/kg, ataxia was severe and loss of righting reflex was frequently observed. These symptoms seem to be due to the anesthetic activity of toluene. Ataxia and the decrease in the brain ACh release occurred at almost same doses of toluene in rats. Injection of pentobarbital abolished the ACh release at 60 mg/kg. This dose of pentobarbital produced complete anesthesia in rats. Anesthesia due to toluene seems to be closely related to the decrease in the ACh release from cholinergic nerve terminals.
Measurement of ACh in the homogenate of the brain striatum and hippocampus revealed that repeated i.p. injection of toluene increases the ACh content of the homogenate in a dose dependent manner. This increase seems to be due to the decrease in ACh release from the nerve endings caused by toluene. As reported in our previous work, a single oral administration of toluene at 1,250 mg/kg had no effect on the ACh content of hippocampal homogenate 27) . In the present study, a single i.p. injection of toluene did not affect the ACh content of the homogenate (data not shown). The amount of extracellular ACh existing in the synaptic clefts is much smaller than the intracellular ACh, so that the amount of ACh measured in the homogenate is nearly equal to that in nerve cells, particularly in the nerve endings. This may be why the decrease in the amount of extracellular ACh induced by toluene did not reflect the increase in ACh in homogenate after a single administration. Repeated administration was needed to increase ACh in homogenate in the case of toluene.
Repeated inhalation exposure of rats to toluene gas 8 h a d for 7 d at 50 to 2,000 ppm increased the ACh content of rat brain homogenate (Honma & Suda, unpublished observation) . These results mean that inhalation exposure to toluene increases the intracellular concentration of ACh. Considering the increased ACh in the homogenate after repeated injection of toluene and the reduced ACh release from the cholinergic nerve endings measured in the microdialysis, the increase in intracellular ACh after inhalation exposure to toluene seems to be due to the reduced ACh release produced by toluene. The increase in ACh in the homogenate could be a good marker of the decrease in ACh release, e.g., lowered activity of cholinergic neurons in acute exposure. Continuous inhalation exposure to toluene for 30 d produced a decrease in ACh content of rat brain homogenate 15) . This may be caused by changes in ACh metabolism, e.g., decreased ACh synthesis, after long continuous exposure.
In our previous study, rats received oral administration of each of 28 organic solvents at one-quarter the oral LD 50 value, and hippocampus ACh was measured 2 h later 27) . Many chemicals in these 28 solvents produced increases in ACh. The decrease in ACh release from the nerve endings may be caused by the injection of these many kinds of organic solvents. Anesthetic action is widely observed in organic solvents. The decrease in the activity of cholinergic neurons might be common to the activity of many solvents.
Brain content of toluene after i.p. administration of toluene at 1,000 mg/kg reached the maximum at 2-3 h after the injection, and about 200 µg/g tissue was obtained for whole brain. The time course of the decrease in brain extracellular ACh after toluene injection was similar to that of the toluene concentration in the brain. These results suggest that the decrease in brain ACh was due to the direct effects of toluene on the cholinergic neurons. Brain content of toluene decreased with time and was about 100 and 70 µg/g tissue at 4 and 8 h, respectively, after the injection at 1,000 mg/ kg. After inhalation exposure to toluene at 1,000 ppm for 8 h, brain content of toluene was about 16 µg/g tissue at 30 min after the cessation of exposure, and 6 and 3 µg/g tissue at 3 and 6 h, respectively. Because the concentrations of toluene in rat brain reached the maximum quickly after the start of exposure and lasted constant during the exposure 28) , a simplified simulation model was obtained for the time course of tissue toluene in inhalation exposure to toluene (Fig. 9) . As shown in Table 1 , the cumulative exposure to the i.p. administration of toluene at 1,000 mg/kg seems to be about 5 to 10 times higher than that for 8-h inhalation at 1,000 ppm, but this ratio is dependent on the injection doses and exposure concentrations (Fig. 10 ). Using the above ratio, 5, the i.p. injection at 200 or 500 mg/kg is almost equivalent to 8-h inhalation exposure at 1,000 to 2,500 ppm, from the viewpoint of time integration. When the ratio 10 is used, the doses of 200 to 500 mg/kg in i.p. injection are almost equivalent to 2,000 to 5,000 mg/kg in 8-h inhalation exposure. Considering the effects of toluene injection at 200 or 500 mg/kg in lowering the extracellular ACh, the inhalation exposure to toluene at 1,000 to 5,000 ppm for 8 h might be effective in lowering the activity of cholinergic neurons.
As to the effects of toluene on the neurotransmitters, several microdialysis studies have been reported. Inhalation exposure of rats to 1,000 or 2,000 ppm toluene for 2 h increased extracellular levels of striatal dopamine 29) . Kondo et al. showed that i.p. injection of toluene up to 800 mg/kg had no significant effect on brain extracellular content of dopamine, 3, 4-dihydroxyphenylacetic acid, homovanillic acid or 5-hyrdoxyindoleacetic acid in rat striatum measured by microdialysis 30) . Gerasimov et al. reported that inhalation of 3,000 ppm toluene produced a significant increase in dopamine in the prefrontal cortex but not in the nucleus accumbens 31) . The effects of toluene on extracellular dopamine may depend on the brain region. According to Stengård 32) , inhalation of 2,000 ppm toluene for 2 h reduced extracellular ACh in the striatum. An ACh decrease due to toluene was consistent with our results 17) . Our present study clarified that toluene reduces extracellular ACh both in the striatum and hippocampus in a dose dependent manner. These effects of toluene seem to occur at 1,000 ppm or higher exposure concentrations in an 8 h exposure condition. Cholinergic neurons are involved in the learning and memory functions. The hippocampus is the important area for the control and retention of memory 33) . Considering these backgrounds, the inhibitory effects of toluene on the hippocampal cholinergic neurons might be related to memory and other disorders in human toluene poisoning. Dysfunction of learning and memory after acute exposure to a high concentration of toluene seems to be correlated with the decreased activity of cholinergic neurons in the brain.
